Primary Immune Deficiency Treatment Consortium (PIDTC)

Primary Immune Deficiency Treatment Consortium. You Can Help Move Research Forward

The Primary Immune Deficiency (PID) Treatment Consortium (PIDTC) consists of 13 major centers in North America whose shared goal is to improve the outcome of patients with rare, life threatening, inherited disorders of the immune system. The PIDTC Can Help You:

Learn more about inherited disorders of the immune system including newborn screening
Quickly connect with experts in a PIDTC center in your area who diagnose and treat inherited immune disorders

Learn about treatment options and new research studies for patients with these diseases
Help answer questions your physician may have about immune disorders
Connect with patient support groups

Participating Clinical Centers

Publications

Coming Soon:

Diseases In Depth
Finding Answers: How can I join PITDC Research
Refer patients to the Contact Registry

Syndromes Defined:

Frequently Asked Questions

Advocacy: Find patient groups and national organizations

Join a Study: Find Information About Current Research

Stay
Informed of PIDTC Studies!

How Can I Help? - Why your Participation Matters

What is the PIDTC? | PIDTC Contact Information | Contact the Web Master | Accessibility | Disclaimer

Department of Health and Human Services

National Institutes of Health

National Institute of Allergy and Infectious Diseases

The Primary Immune Dificiency Treatment Consortium (PIDTC) is a part of NIH Rare Diseases Clinical Research Network (RDCRN). Funding and/or programmatic support for this project has been provided by the National Institute of Allergy and Infectious Diseases (NIAID) and the NIH Office of Rare Diseases Research (ORDR). The views expressed in written materials or publications do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government. Read Disclaimer >